Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 249

Similar articles for PubMed (Select 8633037)

1.

Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5).

Fujimoto J, Shiota M, Iwahara T, Seki N, Satoh H, Mori S, Yamamoto T.

Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4181-6.

2.
3.

The interaction of the ErbB4 intracellular domain p80 with α-enolase in the nuclei is associated with the inhibition of the neuregulin1-dependent cell proliferation.

Yamada S, Marutsuka M, Inoue M, Zhang J, Abe S, Ishibashi K, Yamaguchi N, Eto K.

Int J Biochem Mol Biol. 2014 May 15;5(1):21-9. eCollection 2014.

4.

Phosphorylated STAT3 physically interacts with NPM and transcriptionally enhances its expression in cancer.

Ren Z, Aerts JL, Pen JJ, Heirman C, Breckpot K, De Grève J.

Oncogene. 2015 Mar 26;34(13):1650-7. doi: 10.1038/onc.2014.109. Epub 2014 May 5.

PMID:
24793791
5.

Oncogenic FGFR3 gene fusions in bladder cancer.

Williams SV, Hurst CD, Knowles MA.

Hum Mol Genet. 2013 Feb 15;22(4):795-803. doi: 10.1093/hmg/dds486. Epub 2012 Nov 21.

6.

Chromosomal translocations among the healthy human population: implications in oncogenesis.

Nambiar M, Raghavan SC.

Cell Mol Life Sci. 2013 Apr;70(8):1381-92. doi: 10.1007/s00018-012-1135-x. Epub 2012 Sep 5. Review.

PMID:
22948164
7.

Fusion of dynactin 1 to anaplastic lymphoma kinase in inflammatory myofibroblastic tumor.

Wang X, Krishnan C, Nguyen EP, Meyer KJ, Oliveira JL, Yang P, Yi ES, Erickson-Johnson MR, Yaszemski MJ, Maran A, Oliveira AM.

Hum Pathol. 2012 Nov;43(11):2047-52. doi: 10.1016/j.humpath.2012.02.014. Epub 2012 Jun 1.

PMID:
22658521
8.

Assessment of the transforming potential of novel anaplastic lymphoma kinase point mutants.

McDuff FK, Lim SV, Dalbay M, Turner SD.

Mol Carcinog. 2013 Jan;52(1):79-83. doi: 10.1002/mc.21836. Epub 2011 Nov 15.

PMID:
22086496
9.

[Genomic alterations in malignant lymphoma].

Seto M.

Rinsho Ketsueki. 2011 Oct;52(10):1734-9. Review. Japanese. No abstract available.

PMID:
21971254
10.

Crystal structure of the ALK (anaplastic lymphoma kinase) catalytic domain.

Lee CC, Jia Y, Li N, Sun X, Ng K, Ambing E, Gao MY, Hua S, Chen C, Kim S, Michellys PY, Lesley SA, Harris JL, Spraggon G.

Biochem J. 2010 Sep 15;430(3):425-37. doi: 10.1042/BJ20100609.

PMID:
20632993
11.

Structural basis for the recognition of nucleophosmin-anaplastic lymphoma kinase oncoprotein by the phosphotyrosine binding domain of Suc1-associated neurotrophic factor-induced tyrosine-phosphorylated target-2.

Koshiba S, Li H, Motoda Y, Tomizawa T, Kasai T, Tochio N, Yabuki T, Harada T, Watanabe S, Tanaka A, Shirouzu M, Kigawa T, Yamamoto T, Yokoyama S.

J Struct Funct Genomics. 2010 Jun;11(2):125-41. doi: 10.1007/s10969-010-9091-x. Epub 2010 May 8.

PMID:
20454865
12.

Peripheral T cell lymphoma: new model + new insight.

Mulloy JC.

J Exp Med. 2010 May 10;207(5):911-3. doi: 10.1084/jem.20100608. Epub 2010 May 3.

13.
14.

Oncogenic mutations of ALK kinase in neuroblastoma.

Chen Y, Takita J, Choi YL, Kato M, Ohira M, Sanada M, Wang L, Soda M, Kikuchi A, Igarashi T, Nakagawara A, Hayashi Y, Mano H, Ogawa S.

Nature. 2008 Oct 16;455(7215):971-4. doi: 10.1038/nature07399.

PMID:
18923524
15.

Laforin confers cancer resistance to energy deprivation-induced apoptosis.

Wang Y, Liu Y, Wu C, McNally B, Liu Y, Zheng P.

Cancer Res. 2008 Jun 1;68(11):4039-44. doi: 10.1158/0008-5472.CAN-07-6314.

16.

Characterization of some molecular mechanisms governing autoactivation of the catalytic domain of the anaplastic lymphoma kinase.

Tartari CJ, Gunby RH, Coluccia AM, Sottocornola R, Cimbro B, Scapozza L, Donella-Deana A, Pinna LA, Gambacorti-Passerini C.

J Biol Chem. 2008 Feb 15;283(7):3743-50. Epub 2007 Dec 10.

17.

The tyrosine phosphatase Shp2 interacts with NPM-ALK and regulates anaplastic lymphoma cell growth and migration.

Voena C, Conte C, Ambrogio C, Boeri Erba E, Boccalatte F, Mohammed S, Jensen ON, Palestro G, Inghirami G, Chiarle R.

Cancer Res. 2007 May 1;67(9):4278-86.

18.

Identification of multiple SNT-binding sites on NPM-ALK oncoprotein and their involvement in cell transformation.

Chikamori M, Fujimoto J, Tokai-Nishizumi N, Yamamoto T.

Oncogene. 2007 May 3;26(20):2950-4. Epub 2006 Nov 6.

PMID:
17086210
19.

A "liaison dangereuse" between AUF1/hnRNPD and the oncogenic tyrosine kinase NPM-ALK.

Fawal M, Armstrong F, Ollier S, Dupont H, Touriol C, Monsarrat B, Delsol G, Payrastre B, Morello D.

Blood. 2006 Oct 15;108(8):2780-8. Epub 2006 Jul 11.

20.

Proteomic identification of oncogenic chromosomal translocation partners encoding chimeric anaplastic lymphoma kinase fusion proteins.

Elenitoba-Johnson KS, Crockett DK, Schumacher JA, Jenson SD, Coffin CM, Rockwood AL, Lim MS.

Proc Natl Acad Sci U S A. 2006 May 9;103(19):7402-7. Epub 2006 May 1.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk